Match Document Document Title
7018621 Delivery of rizatriptan or zolmitriptan through an inhalation route  
The present invention relates to the delivery of compounds for the treatment of migraine and headache through an inhalation route. Specifically, it relates to aerosols containing rizatriptan or...
7018619 Delivery of alprazolam, estazolam midazolam or triazolam through an inhalation route  
The present invention relates to the delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route. Specifically, it relates to aerosols containing alprazolam, estazolam,...
7018657 Particulate composition  
Nanoparticles are prepared from a colloidal system comprising a continuous phase and micelles, the micelles comprising surfactant material. A microemulsion is formed by admixing the colloidal...
7018620 Delivery of beta-blockers through an inhalation route  
The present invention relates to the delivery of atenolol, pindolol, esmolol, propranolol, or metoprolol through an inhalation route. Specifically, it relates to aerosols containing atenolol,...
7014841 Delivery of antiemetics through an inhalation route  
The present invention relates to the delivery of antiemetics through an inhalation route. Specifically, it relates to aerosols containing antiemetics that are used in inhalation therapy. In a...
7014840 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route  
The present invention relates to the delivery of anti-migraine compounds through an inhalation route. Specifically, it relates to aerosols containing sumatriptan, frovatriptan, or naratriptan that...
7011819 Delivery of rizatriptan or zolmitriptan through an inhalation route  
The present invention relates to the delivery of headache and anti-migraine compounds through an inhalation route. Specifically, it relates to aerosols containing that are used in inhalation...
7011820 Delivery of compounds for the treatment of Parkinsons through an inhalation route  
The present invention relates to the delivery of antiparkinsons drugs through an inhalation route. In a method aspect of the present invention, an antiparkinsons drug is administered to a patient...
7011818 Carrier particles for use in dry powder inhalers  
A powder for use in a dry powder inhaler includes active particles and carrier particles for carrying the active particles. The powder further includes additive material ( 4 ) on the surfaces of...
7008615 Delivery of anti-migraine compounds through an inhalation route  
The present invention relates to the delivery of anti-migraine compounds through an inhalation route. Specifically, it relates to aerosols containing lidocaine, verapamil, diltiazem, isometheptene,...
7005121 Delivery of compounds for the treatment of migraine through an inhalation route  
The present invention relates to the delivery of a migraine headache drug through an inhalation route. Specifically, it relates to aerosols containing a migraine headache drug that are used in...
6998391 Method for treating diseases associated with abnormal kinase activity  
Methods are provided for treating diseases associated with abnormal activity of kinases. The method comprises: administering a DNA methylation inhibitor to the patient in therapeutically effective...
6998110 Buccal, polar and non-polar spray or capsule  
Buccal aerosol sprays or capsule using polar and non-polar solvent have now been developed which provide biologically active compounds for rapid absorption through the oral mucosa, resulting in...
6994842 Aerogel powder therapeutic agents  
Drugs in the form of very fine highly porous aerogel particles are delivered to a patient via inhalation. The aerogel particles are either an aerogelized form of a pharmaceutical or deposited upon...
6991779 Compositions for treatment or prevention of bioterrorism  
Compositions containing biologically active molecules encapsulated in self-assembling, diketopiperazine microspheres (TECHNOSPHEREs™) and methods for making and administering such compositions...
6984404 Methods for preparing coated drug particles and pharmaceutical formulations thereof  
Disclosed are methods using pulsed laser ablation to prepare coated drug particles of uniform size and thickness. The coated drug particles ranged in size from several nanometers to several...
6982075 Use of pulmonary surfactant  
The invention describes the novel use of pulmonary surfactant preparations in the artificial respiration of patents with toxic oxygen concentrations.
6979437 Pulmonary delivery in treating disorders of the central nervous system  
A method for treating a disorder of the central nervous system includes administering to the respiratory tract of a patient a drug which is delivered to the pulmonary system, for instance to the...
6977087 Aerodynamically light particles for pulmonary drug delivery  
Improved aerodynamically light particles for delivery to the pulmonary system, and methods for their preparation and administration are provided. In a preferred embodiment, the aerodynamically...
6974568 Treatment for cough  
The invention discloses the existence of cannabinoid receptors in the airways, which are functionally linked to inhibition of cough. Locally acting cannabinoid agents can be administered to the...
6974803 Pharmaceutical combination  
The present invention relates to a combination comprising (a) an adenosine A 2a receptor agonist as defined herein and (b) an adrenergic β2 receptor agonist, for simultaneous, sequential or...
6969521 Aerosol insect repellent composition having low VOC content and method of applying same to the skin  
Disclosed is an aerosol insect repellent composition. The composition has (a) an amount of an insect repellent effective to repel insects when applied to the skin and (b) a cosmetically-acceptable...
6967017 Formulations of steroid solutions for inhalatory administration  
The present invention relates to optimized formulations of antiinflammatory steroids for nebulisation and a process for the preparation thereof. More particularly, the invention relates to...
6964759 Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease  
Formulations for the administration through pressurized metered dose aerosol inhalers containing an anticholineric drug in solution in a hydrofluorocarbon propellant, a cosolvent and a low...
6962691 Topical spray compositions  
A topical, medicinal spray composition is provided comprising a drug or combination of drugs in a carrier which, when sprayed on a surface, forms a film. The composition comprises at least one...
6960337 Methods and compositions for treating benign gynecological disorders  
An improvement in a method of treating benign gynecological disorders is described. In the method, treatment of a benign gynecological disorder with a composition comprised of a gonadotropin...
6958142 Nasal spray formulation and method  
A nasal spray formulation for use in female contraception or in the treatment of benign gynecological disorders is described. The nasal preparation is comprised of a GnRH compound and an estrogenic...
6955824 Inhalation composition containing lactose pellets  
This invention relates to a pharmaceutical composition which is suitable for the administration of medicaments by inhalation. In particular, the pharmaceutical composition comprises microfine...
6946117 Stabilized preparations for use in nebulizers  
Stabilized dispersions are provided for the delivery of a bioactive agent to the respiratory tract of a patient. The dispersions preferably comprise a stabilized colloidal system which may comprise...
6946141 As-needed administration of tricyclic and other non-SRI antidepressant drugs to treat premature ejaculation  
A method is provided for treatment of premature ejaculation by administration of an antidepressant drug selected from tricyclic antidepressants, tetracyclic antidepressants, MAO inhibitors,...
6939534 Method to treat pulmonary hypoplasia in the newborn  
A method of treating pulmonary hypoplasia in infants has been developed, wherein epidermal growth factor (EGF) is administered to the pulmonary system of an infant in need of treatment thereof. The...
6936244 Use of bacterial phage associated lysing enzymes for treating streptococcal infections of the upper respiratory tract  
A composition for treatment of bacterial infections of the eye is disclosed which comprises a lytic enzyme composition specific for the infecting bacteria, and a carrier for delivering said lytic...
6932962 Aerosol drug formulations containing hydrofluoroalkanes and alkyl saccharides  
Aerosol formulations suitable for use in pressurised metered dose inhalers comprise a hydrofluoroalkane propellant, an medicament for inhalation and a surfactant which is a a C 8 –C 16 fatty...
6930097 Matrix metalloproteinase and tumor necrosis factor inhibitors  
A compound of formula 1-[3,4-dihydroxy-5-(2-hydroxyethyl)tetrahydrofuran-2-yl]pryi midine-2,4(1H,3H)-dione has inhibitory effects of matrix metalloproteinase-2 (gelatinase A) enzyme and binding of...
6926908 Formulation for inhalation  
Microparticles, obtainable by spray-drying a substantially pure solution of a therapeutic agent, consist essentially of the agent having its therapeutic activity when administered to the lung. In a...
6921527 Composition for pulmonary administration comprising a drug and a hydrophobic amino acid  
According to the subject invention, dispersible dry powder pharmaceutical-based compositions are provided, including methods for their manufacture and dry powder dispersion devices. A dispersible...
6919069 Aerosol formulation containing particulate formoterol, propellant and polar cosolvent  
A pharmaceutical aerosol formulation comprising (i) particulate medicament, (ii) 1,1,1,2-tetrafluoroethane, 1,1,1,2,3,3,3,-heptafluoro-n-propane or a mixture thereof as propellant, and (iii) 0.01...
6913805 Controlled release ampule containing a fumigant  
The present invention provides an apparatus and method for controlled release of a fumigant into a wooden structure to prevent decay of that structure. According to the present invention, a...
6902720 Cyclic peptide structures for molecular scale electronic and photonic devices  
The present invention discloses a family of cyclic peptide monomers and supramolecular cyclic peptide structures comprising chromophore residues which possess electronic and electro-optic...
6893628 Aerosol formulations containing P134a and particulate medicament  
A pharmaceutical formulation comprising (i) one or more particulate medicaments, and (ii) 1,1,1,2-tetrafuoroethane as propellant, which formulation contains less than 0.0001% w/w surfactant based...
6893657 Solid dose delivery vehicle and methods of making same  
The present invention encompasses a solid dose delivery vehicle for ballistic administration of a bioactive material to subcutaneous and intradermal tissue, the delivery vehicle being sized and...
6890517 Inhalable formulation of a solution containing a tiotropium salt  
A liquid, propellant-free pharmaceutical preparation comprising: (a) a first active substance comprising a tiotropium salt, in a concentration based on tiotropium of between 0.0005% and 5%...
6890518 Compositions of chemically modified insulin  
The present invention provides active, hydrophilic polymer-modified derivatives of insulin. The insulin derivatives of the invention are, in one aspect, suitable for delivery to the lung and...
6887459 Aerosol composition comprising formoterol  
The use of a dry powder comprising (A) formoterol, or a pharmaceutically acceptable salt or solvate thereof, or solvate of said salt, and (B) a pharmaceutically acceptable particulate diluent or...
6881398 Therapeutic dry powder preparation  
A therapeutic dry powder preparation and a method of administering such a preparation are disclosed for effectively de-aggregating and dispersing into air a dose of medication powder in an...
6881757 Aerosol biliquid foam  
Pressurized mixtures of propellant gasses and liquid surface or air treating materials are disclosed. The liquid materials are in the form of a dispersion which is a biliquid foam with a thickener,...
6881725 Method for treating pain  
The present invention is directed to a method of treating pain. The method comprises administering to a subject a pharmaceutical composition comprising an effective amount of a P2X receptor...
6875449 Crystal structure  
A process for the production of crystals with controlled surface smoothness, size, shape and degree of crystallinity, compositions comprising such crystals, and the use of certain crystals,...
6869613 Sprayable insecticidal compositions having enhanced efficacy  
There is provided a sprayable insecticidal composition having significantly increased efficacy which comprises an effective amount of an insecticide; an abrasive; a low level of a surfactant; an...
6867199 Dinucleoside polyphosphate compositions and their therapeutic use  
The present invention relates to certain novel dinucleoside polyphosphates of general Formulae I, II and III, and formulations thereof which are selective ligands of the P2Y purinergic receptors....